Stay updated on BMS-986016 Safety Study with or without Nivolumab Clinical Trial

Sign up to get notified when there's something new on the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:10:14.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety and tolerability of BMS-986016 and Nivolumab in patients with advanced solid tumors.
    Difference
    0.2%
    Check dated 2024-06-06T14:21:59.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide a detailed explanation of eligibility criteria, including examples such as general health condition or prior treatments, and directs users to additional resources for more information.
    Difference
    18%
    Check dated 2024-05-22T21:04:15.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:21:38.000Z thumbnail image

Stay in the know with updates to BMS-986016 Safety Study with or without Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page.